VRXA
Veraxa Biotech Holding AG
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 424B5 | 8/10/2026 | View on SEC |
| 424B5 | 8/10/2026 | View on SEC |
| EFFECT | 8/6/2026 | View on SEC |
| EFFECT | 8/6/2026 | View on SEC |
| F-1/A | 8/5/2026 | View on SEC |
| F-1/A | 8/5/2026 | View on SEC |
| F-1 | 7/31/2026 | View on SEC |
| F-1 | 7/31/2026 | View on SEC |
| 6-K | 7/31/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VRXA |
| Company Name | Veraxa Biotech Holding AG |
| CIK | 2079109 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | V8 |
| Phone | 41443858450 |